AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

STARPHARMA HOLDINGS LTD

0.720

+0.0050.70%

Volume:2.84M

Turnover:2.06M

Market Cap:343.48M

PE:-42.35

High:0.740

Open:0.725

Low:0.715

Close:0.715

52wk High:0.815

52wk Low:0.107

Shares:477.05M

Float Shares:347.84M

Volume Ratio:1.87

T/O Rate:0.82%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.017

EPS(LYR):-0.020

ROE:-45.55%

ROA:-21.00%

PB:24.93

PE(LYR):-36.00

Loading ...

Overview Company News Filings

Company Profile

Company Name:

STARPHARMA HOLDINGS LTD

Exchange:

ASX

Establishment Date:

1997

Employees:

50

Office Location:

4-6 Southampton Crescent,Abbotsford,Victoria,Australia

Website:

http://starpharma.com

Zip Code:

3067

Phone:

Fax:

61 3 9510 5955

Introduction:

Starpharma Holdings Limited engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company focuses on the development of VivaGel, which has completed Phase III clinical trials for the management and prevention of bacterial vaginosis, and as a condom coating for the prevention of sexually transmitted infections, as well as VivaGel condom, an antiviral condom. It also develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase 1/2 clinical trial, and DEP irinotecan that is in phase 1/2 clinical trials for the treatment of solid tumors. The company was founded in 1996 and is headquartered in Abbotsford, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/SPL.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SPL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SPL.AU\",,,,,undefined,":{"symbol":"SPL.AU","market":"AU","secType":"STK","nameCN":"STARPHARMA HOLDINGS LTD","latestPrice":0.72,"timestamp":1788156720000,"preClose":0.715,"halted":0,"volume":2835328,"delay":0,"changeRate":0.006993006993007,"nameEN":"STARPHARMA HOLDINGS LTD","floatShares":347835291,"shares":477054949,"eps":-0.017,"marketStatus":"Not Yet Opened","change":0.005,"latestTime":"08-31 16:12:00 AEST","open":0.725,"high":0.74,"low":0.715,"amount":2062949,"amplitude":0.034965,"askPrice":0.735,"askSize":30000,"bidPrice":0.71,"bidSize":105,"shortable":3,"etf":0,"ttmEps":-0.017,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1788220800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.715,"openAndCloseTimeList":[[1788134400000,1788156000000]],"volumeRatio":1.870985,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"SPL.AU","preClose":0.715,"auctionPrice":0.72,"auctionVolume":87867,"auction":3,"marketStatus":"盘后竞价","timestamp":1788156603759}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SPL.AU\",,,,,undefined,":{"symbol":"SPL.AU","floatShares":347835291,"roa":"-21.00%","roe":"-45.55%","lyrEps":-0.02,"volumeRatio":1.870985,"shares":477054949,"dividePrice":0,"high":0.74,"amplitude":0.034965,"preClose":0.715,"low":0.715,"week52Low":0.107,"pbRate":"24.93","psRate":"27.11","week52High":0.815,"institutionHeld":0,"latestPrice":0.72,"committee":-0.993024,"eps":-0.017,"divideRate":0,"volume":2835328,"delay":0,"ttmEps":-0.017,"open":0.725,"prevYearClose":0.351,"prevWeekClose":0.715,"prevMonthClose":0.75,"prevQuarterClose":0.682,"fiveDayClose":0.725,"twentyDayClose":0.745,"sixtyDayClose":0.736},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SPL.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2026-07-17","symbol":"SPL.AU","defaultRemindTime":1784246400000,"type":"split","dateTimestamp":1784210400000,"forFactor":974214,"toFactor":1000000,"ratio":0.974214}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SPL.AU\",market:\"AU\",,,undefined,":[],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":4493458,"yearFounded":1997,"employeeNum":50,"address":"4-6 Southampton Crescent,Abbotsford,Victoria,Australia","zipCode":"3067","officePhone":"61 3 8532 2700","officeFax":"61 3 9510 5955","fiscalYearEnd":"06-30"},"stockCompanyDetail":{"websiteUrl":"http://starpharma.com","stockEarnings":[{"period":"1week","weight":-0.0069},{"period":"1month","weight":-0.04},{"period":"3month","weight":-0.0217},{"period":"6month","weight":1},{"period":"1year","weight":4.9016},{"period":"ytd","weight":1.0513}],"compareEarnings":[{"period":"1week","weight":-0.0084},{"period":"1month","weight":-0.0142},{"period":"3month","weight":0.0607},{"period":"6month","weight":0.0479},{"period":"1year","weight":0.1042},{"period":"ytd","weight":0.048}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Starpharma Holdings Limited engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company focuses on the development of VivaGel, which has completed Phase III clinical trials for the management and prevention of bacterial vaginosis, and as a condom coating for the prevention of sexually transmitted infections, as well as VivaGel condom, an antiviral condom. It also develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase 1/2 clinical trial, and DEP irinotecan that is in phase 1/2 clinical trials for the treatment of solid tumors. The company was founded in 1996 and is headquartered in Abbotsford, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.538462,"avgChangeRate":0.019366},{"month":2,"riseRate":0.346154,"avgChangeRate":-0.019367},{"month":3,"riseRate":0.384615,"avgChangeRate":0.02555},{"month":4,"riseRate":0.307692,"avgChangeRate":-0.017937},{"month":5,"riseRate":0.346154,"avgChangeRate":-0.039405},{"month":6,"riseRate":0.576923,"avgChangeRate":0.041309},{"month":7,"riseRate":0.423077,"avgChangeRate":0.002565},{"month":8,"riseRate":0.68,"avgChangeRate":0.099247},{"month":9,"riseRate":0.5,"avgChangeRate":0.017785},{"month":10,"riseRate":0.461538,"avgChangeRate":-0.016562},{"month":11,"riseRate":0.5,"avgChangeRate":0.028116},{"month":12,"riseRate":0.461538,"avgChangeRate":-0.006043}],"exchange":"ASX","name":"STARPHARMA HOLDINGS LTD","nameEN":"STARPHARMA HOLDINGS LTD"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"SPL.AU\",market:\"AU\",,,undefined,":null}}